Dr.
Afsaneh Motamed
Khorasani,
PhD, is a Medical
and scientific
Affairs expert and a
Senior Scientist
with a strong
background in
biomedical science
and clinical
trial/research. She
has a tenured and
diverse range of
experience in
medical affairs,
basic and industrial
clinical research
and development,
clinical trials,
Medical and
regulatory writing
and intellectual
property. She is
currently the Vice
President of Medical
Affairs at Easy
Global Training,
which is a US-based
firm providing
global regulatory,
quality and medical
affairs training
backed by
consulting.
Before joining
this company, Dr.
Motamed Khorasani
has served as an
independent
consultant, director
of medical affairs,
senior medical
sciences liaison,
senior scientist and
senior medical
analyst at Merck
(MDS), Johnson &
Johnson, United
States Pharmacopeia
Convention (USP),
Amgen, Baxter
International,
Covidien (eV3),
Radient
Pharmaceuticals,
AMDL Diagnostics,
Microbix Biosystems,
Neometrix
Consulting, Mount
Sinai Hospital,
Princess Margaret
Hospital, and
Vancouver General
Hospital.
She has more than
20 years of
experience and many
National and
international
certificates in GLP,
GMP, ICH-GCP and
global regulatory
compliance for
clinical trials and
is a member in a
number of
professional
associations,
including: American
Association of
Cancer Research
(AACR), American
Medical Writers
Association (AMWA),
Regulatory Affairs
Professional Society
(RAPS), American
Society of Quality
(ASQ), Project
Management Institute
(PMI), and
Intellectual
Property Institute
of Canada (IPIC).
Dr. Motamed
Khorasani's research
has focused on high
throughput
approaches in the
context of cancer
informatics with a
particular interest
in the use of
comparative analysis
for the mining of
integrated oncology
datasets that
include
protein-protein
interaction and gene
expression
profiling. She has
published and
presented more than
50 papers, abstracts
and articles in
highly regarded
scientific journals
and high profile
conferences and
scientific meetings.